Citra-Lock™ S Prefilled Syringes

Catheter lock solution, anti-clotting and antimicrobial is one of the innovations from Dirinco

Citra-Lock™ is recommended in the European Renal Best Practice Guidelines (ERBP) and the American Society of Diagnostic and Interventional Nephrology (ASDIN).

  • Citra locks have been extensively studied.
  • Citra-Lock™ is effective in maintaining catheter patency.

Clinical advantage of Citra-Lock™

  • safe
  • avoids heparin-associated bleeding
  • improves reliability of INR assyas (prothrombin time – time/international normalised ratio)
  • safe for heparin induced thrombocytopenia (HIT patients)
  • no side effects
  • reduction of tPA use
  • better outcomes over catheter exchange
  • reduces biofilm
  • reduction of hospitalisation
  • cost efficient

Citra-Lock™S 46,7%

Using Citra-Lock 46,7% improves overall patency rates reduces catheter-related infections...

Citra-Lock™S 30%

Using Citra-Lock 30% improves overall patency rates reduces catheter-related infections...

Citra-Lock™S 4%

Citra-Lock 4% is recommended in the European Renal Best Practice...

Citra-Lock™ 30%

Using Citra-Lock 30% improves overall patency rates reduces catheter-related infections...

Citra-Lock™ 46,7%

Using Citra-Lock 46,7% improves overall patency rates reduces catheter-related infections...

Access innovation

Citra-Gen products are part of international recommended guidelines of today, defined by clinicians. Citra-Gen presents its products worldwide through a global network of dedicated distributors. Therefore, Citra-Gen is able to offer a high level of support to local customers.

Effective range of biocompatible catheters, prepared for state of the art blood flows.

— Citra-XS™ Catheters

Citra-Lock™ is recommended in the European Renal Best Practice Guidelines (ERBP) and the American Society of Diagnostic and Interventional Nephrology (ASDIN).

— Citra-Lock™